Influenza vaccination and antimicrobial resistance: strategic recommendations

  12 June 2021

Antimicrobial resistance (AMR) is an increasing threat to global health. Vaccination has received heightened attention as an approach to combat antibiotic use and possibly AMR. Vaccination can prevent bacterial and viral infections that may otherwise be treated, sometimes inappropriately, with antimicrobial medicines. WHO has stated that increased uptake of influenza vaccines should be prioritized for its impact on antibiotic use and AMR. This reports aims to assess the association between influenza vaccination and AMR, and develop strategic recommendations regarding the implementation of influenza vaccination within a global strategy to combat AMR.

Further reading: NIVEL
Author(s): Heuvel. L. van, Caini, S., Dückers, M., Paget, J.
Effective Surveillance  
Back

OUR UNDERWRITERS

Unrestricted financial support by:

Antimicrobial Resistance Fighter Coalition

Evotec

JSS University

INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS





Technology Database

Display your AMR Technology, Product and Service

Suppliers and Users of Technologies, Products and Services benefit from CAPI.
CAPI (Continuous AMR Partnering Initiative) unites Suppliers and Users worldwide with the aim to add to the curbing of AMR.

Read more and make your own Technology Page >>
What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!